Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Beginning Cash Balance (2018 - 2019)

Acro Biomedical has reported Beginning Cash Balance over the past 2 years, most recently at $50000.0 for Q4 2019.

  • Quarterly results put Beginning Cash Balance at $50000.0 for Q4 2019, down 64.62% from a year ago — trailing twelve months through Sep 2022 was $95000.0 (changed 0.0% YoY), and the annual figure for FY2019 was $95001.0, changed.
  • Beginning Cash Balance for Q4 2019 was $50000.0 at Acro Biomedical, up from $45000.0 in the prior quarter.
  • Over the last five years, Beginning Cash Balance for ACBM hit a ceiling of $141336.0 in Q4 2018 and a floor of $45000.0 in Q3 2019.